<\/p>\n
The European Hematology Association held their virtual congress from 9-17 June \u2013 it remains online until 15 August here<\/a>. Many studies were presented, key among them was one titled: Humoral Response to the Pfizer\/BioNTech BNT162b2 Vaccine Is Impaired in Patients Receiving CAR-T or High-Intensity Immunosuppressive Therapy.<\/p>\n
This study presentation and others can be accessed at the EHA21 Virtual Congress<\/a>. The education and scientific program of the congress focuses on clinical practice, recent advances, new data and views from different stakeholders and international organizations. Registration is open until 1 August and the sessions are online until 15 August.<\/p>\n